Imidazo 1,2-a pyrimidine derivatives for the treatment of diseases such as diabetes

US8278312B2 · kind B2 · utility

Assignee

• MERCK PATENT GESELLSCHAFT MIT BESHRANK TER HAFTUNG · DE

Inventors

• Markus Klein · Weiterstadt, DE
• Werner Mederski · Zwingenberg, DE
• Christos Tsaklakidis · Weinheim, DE
• Norbert Beier · Reinheim, DE

Key dates

• Filing date: Sep 13, 2008
• Grant date: Oct 2, 2012
• Expiry date: Mar 2, 2029

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P37/06
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Novel compounds of the formula (I), in which W, T, R1, R2, R3, R4, R5, R6 and X7 have the meanings indicated in Patent Claim 1, are suitable as antidiabetics.